Skip to main content

ABBOTT LABORATORIES

CIK 0000001800

ABTNYSEPharmaceutical Preparations (SIC 2834)Fiscal year ends in late December

Fiscal 2025

From the 10-K filed 2026-02-20, year ended 2025-12-31

Revenue

$44.33B

Up 5.7% on 2024

Net income

$6.52B

Down 51.3% on 2024

Operating income

$8.05B

As reported

Diluted EPS

$3.72

Per share, as reported

Free cash flow

$7.39B

Calculated

Free cash flow is not a line in the filing. It is calculated as operating cash flow minus capital expenditures for the same year. Revenue uses the tag RevenueFromContractWithCustomerExcludingAssessedTax.

Six years of revenue and net income

RevenueNet income

Every year, with its filing

US dollars in millions. Each accession number opens the filing on sec.gov.
Fiscal yearRevenueNet incomeFormFiled
202544,3286,52410-K2026-02-20
202441,95013,40210-K2025-02-21
202340,1095,72310-K2024-02-16
202243,6536,93310-K2023-02-17
202143,0757,07110-K2022-02-18
202034,6084,49510-K2021-02-19

Get these numbers yourself

The shared demo key works for a quick try. A free key gives 100 calls a day, and agents can pay 0.02 USDC a call with x402.

Read the API docs

curl

curl -H "Authorization: Bearer demo" \
  "https://api.netnestdesign.com/v1/history/ABT/revenue?period=annual&limit=6"

Python

import requests

r = requests.get(
    "https://api.netnestdesign.com/v1/fundamentals/ABT",
    params={"metrics": "revenue,net_income,eps_diluted", "period": "annual"},
    headers={"Authorization": "Bearer demo"},
    timeout=30,
)
for row in r.json()["data"]:
    print(row["metric"], row["value"], row["form"], row["filed_date"])

Data from SEC filings. Not investment advice.